Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 12.15 1.84% 0.22
FLXN closed down 0.67 percent on Monday, March 18, 2019, on 1.71 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical FLXN trend table...

Date Alert Name Type % Chg
Mar 18 Stochastic Buy Signal Bullish 1.84%
Mar 18 Doji - Bullish? Reversal 1.84%
Mar 18 Down 3 Days in a Row Weakness 1.84%
Mar 18 Down 4 Days in a Row Weakness 1.84%
Mar 18 Down 5 Days in a Row Weakness 1.84%
Mar 18 Lower Bollinger Band Touch Weakness 1.84%
Mar 18 Oversold Stochastic Weakness 1.84%
Mar 15 Down 3 Days in a Row Weakness 1.17%
Mar 15 Down 4 Days in a Row Weakness 1.17%
Mar 15 Down 5 Days in a Row Weakness 1.17%

Older signals for FLXN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Chemistry Pain Organic Compounds Organic Chemistry Osteoarthritis Arthritis Glucocorticoids Skeletal Disorders Organofluorides Tropomyosin Receptor Kinase A
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.1
52 Week Low 10.98
Average Volume 645,179
200-Day Moving Average 18.6523
50-Day Moving Average 13.624
20-Day Moving Average 13.478
10-Day Moving Average 12.669
Average True Range 0.7146
ADX 14.9
+DI 13.3856
-DI 24.4289
Chandelier Exit (Long, 3 ATRs ) 13.3662
Chandelier Exit (Short, 3 ATRs ) 13.7288
Upper Bollinger Band 15.3246
Lower Bollinger Band 11.6314
Percent B (%b) 0.08
BandWidth 27.401692
MACD Line -0.498
MACD Signal Line -0.2816
MACD Histogram -0.2164
Fundamentals Value
Market Cap 380.63 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -3.84
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.88
Resistance 3 (R3) 12.87 12.55 12.72
Resistance 2 (R2) 12.55 12.30 12.55 12.67
Resistance 1 (R1) 12.24 12.15 12.08 12.25 12.62
Pivot Point 11.91 11.91 11.83 11.92 11.91
Support 1 (S1) 11.60 11.67 11.44 11.61 11.24
Support 2 (S2) 11.28 11.52 11.28 11.19
Support 3 (S3) 10.97 11.28 11.14
Support 4 (S4) 10.98